Effect of combined therapy with losartan and furosemide in rats with 5/6 nephrectomy (2007)
- Authors:
- USP affiliated authors: ZATZ, ROBERTO - FM ; FUJIHARA, CLARICE KAZUE - FM
- Unidade: FM
- Subjects: NEFRECTOMIA; MEDICAMENTO (EFEITO ADVERSOS); RATOS; RESUMOS (SIMPÓSIOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio avanços em pesquisas médicas
-
ABNT
SOUZA, R. A. et al. Effect of combined therapy with losartan and furosemide in rats with 5/6 nephrectomy. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 12 jan. 2026. , 2007 -
APA
Souza, R. A., Costa, S. R., Romagnolli, C., Moraes, M. C. M., Fujihara, C. K., & Zatz, R. (2007). Effect of combined therapy with losartan and furosemide in rats with 5/6 nephrectomy. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Souza RA, Costa SR, Romagnolli C, Moraes MCM, Fujihara CK, Zatz R. Effect of combined therapy with losartan and furosemide in rats with 5/6 nephrectomy. Clinics. 2007 ; 62 S55.[citado 2026 jan. 12 ] -
Vancouver
Souza RA, Costa SR, Romagnolli C, Moraes MCM, Fujihara CK, Zatz R. Effect of combined therapy with losartan and furosemide in rats with 5/6 nephrectomy. Clinics. 2007 ; 62 S55.[citado 2026 jan. 12 ] - The inflammatory component in progressive renal disease: are interventions possible
- An extremely high dose of losartan affords superior renoprotection in the remnant model
- Chronic inhibition of nuclear factor-kB attenuates renal injury in the 5/6 renal ablation model
- Effects of an endothelin et receptor antagonist on experimental fk506 induced acute renal dysfunction
- Hypertension and progressive renal injury induced by salt overload in rats preconditioned by temporary nitric oxide (NO) inhibition
- O efeito do tratamento tardio com alta dose de losartan (L) no modelo de ablação renal de 5/6 (NX)
- Extremely high doses of Losartan (L) prevent renal injuryin the remnant kidney model (NX) by an antiinflammatory rather than glomerular hemodynamic effect
- Mechanisms of progressive renal disease: role of angiotensin II, cyclooxygenase products and nitric oxide
- Early temporary with the AT1 blocker Losartan (L), in high dose or associated with Mycophenolate Mofetil (MMF), limits future injury in the remnant kidney
- Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
